SIAP
DARE icon

Sterling Investment Advisors (Pennsylvania)’s Dare Bioscience DARE Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-49
Closed -$2K – 347
2017
Q3 		$2K Hold
49
– – ﹤0.01% 328
2017
Q2 		$3K Hold
49
– – ﹤0.01% 342
2017
Q1 		$5K Hold
49
– – ﹤0.01% 303
2016
Q4 		$4K Buy
+49
New +$4.67K ﹤0.01% 278

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
II
Inspire Investing Meridian, Idaho $1.71B AUM 31.76% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s DARE Position: Q4 2017 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Dare Bioscience (DARE) in Q4 2017, closing a stake of 49 shares — an estimated $2K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in DARE in Q4 2016 and held it in 4 quarters. The position peaked at $5K in Q1 2017. 14 funds tracked by Wall St. Rank hold DARE as of Q4 2017.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Dare Bioscience position as of Q4 2017 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 49 Dare Bioscience shares in Q4 2017, an estimated $2K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Dare Bioscience in Q4 2016 and held it in 4 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Dare Bioscience position peaked at $5K in Q1 2017.
  • 14 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2017.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q4 2017, filed 29 Jan 2018.